Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3075% below fair value
$1.51+0.15 (+11.03%)
Close on Nov 13, 2026Market cap $113.64MP/E –Yield –
Health Catalyst ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Health Catalyst's ebitda for the twelve months ending Sep 30, 2026 was -$133.20M. For fiscal 2025 it was -$110.35M. The highest annual figure on record is -$28.38M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$110.35M | – |
| FY2024 | Dec 31, 2024 | -$28.38M | – |
| FY2023 | Dec 31, 2023 | -$84.67M | – |
| FY2022 | Dec 31, 2022 | -$91.71M | – |
| FY2021 | Dec 31, 2021 | -$106.12M | – |
| FY2020 | Dec 31, 2020 | -$77.40M | – |
| FY2019 | Dec 31, 2019 | -$45.65M | – |
| FY2018 | Dec 31, 2018 | -$52.68M | – |
| FY2017 | Dec 31, 2017 | -$39.65M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $59.87M | – |
| Q2 FY2026 | Jun 30, 2026 | -$25.50M | – |
| Q1 FY2026 | Mar 31, 2026 | -$94.36M | – |
| Q4 FY2025 | Dec 31, 2025 | -$73.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.90M | – |
| Q2 FY2025 | Jun 30, 2025 | -$24.41M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.85M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.29M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.88M | – |
| Q1 FY2023 | Mar 31, 2023 | -$23.92M | – |
| Q4 FY2022 | Dec 31, 2022 | -$25.08M | – |
| Q3 FY2022 | Sep 30, 2022 | -$33.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.84M | – |
| Q3 FY2021 | Sep 30, 2021 | -$31.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$24.18M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.50M | – |
| Q4 FY2020 | Dec 31, 2020 | -$31.15M | – |
| Q3 FY2020 | Sep 30, 2020 | -$18.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.23M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.30M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.42M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.15M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$10.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.34M | – |
| Q2 FY2018 | Jun 30, 2018 | -$17.26M | – |
See a number that looks wrong?